Recent News

• 06.29.2026 - Company deck – Q3 2026
• 06.29.2026 - מצגת חברה – Q3 2026
• 06.14.2026 - Israeli Biotech’s bittersweet solution to climate change
• 04.19.2026 - Company deck – Q2 2026
• 04.19.2026 - מצגת חברה – Q2 2026
• 11.18.2025 - Pluri Enters the Beauty Industry (5th section of article)
• 11.16.2025 - Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regenerative Skincare
• 11.16.2025 - Summary of the Last Week in Israeli Tech
• 11.16.2025 - Pluri Announces Global Foodtech and Agtech Collaborations Across Asia, Europe, and the U.S.
• 11.09.2025 - Autologous Cell Therapies: Shoring Up Supply Chains for Scalability

Recent Filings

• 07.01.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.01.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 06.22.2026 - 8-K Current report
• 06.01.2026 - 8-K Current report
• 05.14.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.01.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 04.23.2026 - ARS Annual Report to Security Holders
• 04.23.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.23.2026 - DEF 14A Other definitive proxy statements